| General information | Literature | Expression | Regulation | Mutation | Homolog | Interaction |
Basic Information | |
|---|---|
Gene ID | 1432 |
Name | MAPK14 |
Synonym | CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA;mitogen-activated protein kinase 14;MAPK14;mitogen-activated protein kinase 14 |
Definition | CSAID-binding protein|Csaids binding protein|MAP kinase 14|MAP kinase Mxi2|MAP kinase p38 alpha|MAX-interacting protein 2|cytokine suppressive anti-inflammatory drug binding protein|cytokine suppressive anti-inflammatory drug-binding protein|mitogen-activ |
Position | 6p21.3-p21.2 |
Gene Type | protein-coding |
Pathways and Diseases | |
Pathway | Atypical NF-kappaB pathway;PID Curated;200017 |
Pathway | Signaling in Immune system;Reactome;REACT:6900 |
Pathway | RAC1 signaling pathway;PID Curated;200190 |
Pathway | Regulation of p38-alpha and p38-beta;PID Curated;200054 |
Pathway | Neurotrophin signaling pathway;KEGG PATHWAY;hsa04722 |
Pathway | nfkb activation by nontypeable hemophilus influenzae;PID BioCarta;100088 |
Pathway | bcr signaling pathway;PID BioCarta;100227 |
Pathway | RIG-I-like receptor signaling pathway;KEGG PATHWAY;hsa04622 |
Pathway | MAPK signaling pathway;KEGG PATHWAY;hsa04010 |
Pathway | Interferon-gamma signaling pathway;PANTHER;P00035 |
Pathway | Retinoic acid receptors-mediated signaling;PID Curated;200142 |
Pathway | Role of Calcineurin-dependent NFAT signaling in lymphocytes;PID Curated;200076 |
Pathway | TGF-beta signaling pathway;PANTHER;P00052 |
Pathway | IL12-mediated signaling events;PID Curated;200034 |
Pathway | ATF-2 transcription factor network;PID Curated;200116 |
Pathway | regulation of map kinase pathways through dual specificity phosphatases;PID BioCarta;100185 |
Pathway | Toll receptor signaling pathway;PANTHER;P00054 |
Pathway | Toxoplasmosis;KEGG PATHWAY;hsa05145 |
Pathway | FGF signaling pathway;PANTHER;P00021 |
Pathway | CXCR3-mediated signaling events;PID Curated;200150 |
Pathway | BCR signaling pathway;PID Curated;200005 |
Pathway | VEGF signaling pathway;KEGG PATHWAY;hsa04370 |
Pathway | human cytomegalovirus and map kinase pathways;PID BioCarta;100149 |
Pathway | Angiopoietin receptor Tie2-mediated signaling;PID Curated;200066 |
Pathway | p53 pathway;PID Curated;200175 |
Pathway | il12 and stat4 dependent signaling pathway in th1 development;PID BioCarta;100133 |
Pathway | mapkinase signaling pathway;PID BioCarta;100113 |
Pathway | EPO signaling pathway;PID Curated;200157 |
Pathway | NOD-like receptor signaling pathway;KEGG PATHWAY;hsa04621 |
Pathway | CDC42 signaling events;PID Curated;200057 |
Pathway | gata3 participate in activating the th2 cytokine genes expression;PID BioCarta;100157 |
Pathway | control of skeletal myogenesis by hdac and calcium/calmodulin-dependent kinase (camk);PID BioCarta;100148 |
Pathway | Rapid glucocorticoid signaling;PID Curated;200090 |
Pathway | Amyotrophic lateral sclerosis (ALS);KEGG PATHWAY;hsa05014 |
Pathway | Shigellosis;KEGG PATHWAY;hsa05131 |
Pathway | EGF receptor signaling pathway;PANTHER;P00018 |
Pathway | Leukocyte transendothelial migration;KEGG PATHWAY;hsa04670 |
Pathway | Endothelins;PID Curated;200004 |
Pathway | CD40/CD40L signaling;PID Curated;200031 |
Pathway | Hepatitis C;KEGG PATHWAY;hsa05160 |
Pathway | Signalling by NGF;Reactome;REACT:11061 |
Pathway | Regulation of Androgen receptor activity;PID Curated;200102 |
Pathway | map kinase inactivation of smrt corepressor;PID BioCarta;100032 |
Pathway | tsp-1 induced apoptosis in microvascular endothelial cell;PID BioCarta;100010 |
Pathway | Parkinson disease;PANTHER;P00049 |
Pathway | transcription factor creb and its extracellular signals;PID BioCarta;100198 |
Pathway | signal transduction through il1r;PID BioCarta;100132 |
Pathway | bioactive peptide induced signaling pathway;PID BioCarta;100226 |
Pathway | VEGF signaling pathway;PANTHER;P00056 |
Pathway | B cell activation;PANTHER;P00010 |
Pathway | Progesterone-mediated oocyte maturation;KEGG PATHWAY;hsa04914 |
Pathway | p38 mapk signaling pathway;PID BioCarta;100085 |
Pathway | keratinocyte differentiation;PID BioCarta;100119 |
Pathway | toll-like receptor pathway;PID BioCarta;100013 |
Pathway | Epithelial cell signaling in Helicobacter pylori infection;KEGG PATHWAY;hsa05120 |
Pathway | S1P2 pathway;PID Curated;200181 |
Pathway | links between pyk2 and map kinases;PID BioCarta;100057 |
Pathway | IL4-mediated signaling events;PID Curated;200018 |
Pathway | il-10 anti-inflammatory signaling pathway;PID BioCarta;100134 |
Pathway | Angiogenesis;PANTHER;P00005 |
Pathway | fmlp induced chemokine gene expression in hmc-1 cells;PID BioCarta;100162 |
Pathway | Myogenesis;Reactome;REACT:21303 |
Pathway | GnRH signaling pathway;KEGG PATHWAY;hsa04912 |
Pathway | Ras Pathway;PANTHER;P04393 |
Pathway | Alzheimer disease-amyloid secretase pathway;PANTHER;P00003 |
Pathway | Chagas disease;KEGG PATHWAY;hsa05142 |
Pathway | JAK/STAT signaling pathway;PANTHER;P00038 |
Pathway | Fc epsilon RI signaling pathway;KEGG PATHWAY;hsa04664 |
Pathway | p38 signaling mediated by MAPKAP kinases;PID Curated;200135 |
Pathway | Thromboxane A2 receptor signaling;PID Curated;200069 |
Pathway | Toll-like receptor signaling pathway;KEGG PATHWAY;hsa04620 |
Pathway | FAS (CD95) signaling pathway;PID Curated;200067 |
Pathway | Hemostasis;Reactome;REACT:604 |
Pathway | ADP signalling through P2Y purinoceptor 1;PID Reactome;500292 |
Pathway | the 41bb-dependent immune response;PID BioCarta;100257 |
Pathway | tnf/stress related signaling;PID BioCarta;100026 |
Pathway | Oxidative stress response;PANTHER;P00046 |
Pathway | IL6-mediated signaling events;PID Curated;200124 |
Pathway | p53 pathway feedback loops 2;PANTHER;P04398 |
Pathway | Leishmaniasis;KEGG PATHWAY;hsa05140 |
Pathway | Trk receptor signaling mediated by the MAPK pathway;PID Curated;200182 |
Pathway | T cell receptor signaling pathway;KEGG PATHWAY;hsa04660 |
Pathway | regulation of eif-4e and p70s6 kinase;PID BioCarta;100178 |
Pathway | IL2-mediated signaling events;PID Curated;200082 |
Disease | Pre-Eclampsia;FunDO |
Disease | Ischemia;FunDO |
Disease | Heart failure;FunDO |
Disease | Tuberculosis;FunDO |
Disease | Diabetes mellitus;FunDO |
Disease | Dermatitis;FunDO |
Disease | Rheumatic fever;FunDO |
Disease | Enteritis;FunDO |
Disease | Systemic scleroderma;FunDO |
Disease | Rheumatoid arthritis;FunDO |
Disease | Chronic obstructive airway disease;FunDO |
Disease | Skin cancer;FunDO |
Disease | Severe acute respiratory syndrome;FunDO |
Disease | Amyotrophic lateral sclerosis;FunDO |
Disease | Cancer;FunDO |
Disease | Schistosoma mansonii infection;FunDO |
Disease | Endometriosis;FunDO |
Disease | HIV infection;FunDO |
Disease | Vascular disease;FunDO |
External Links | |
Links to Entrez Gene | 1432 |
Links to all GeneRIF Items | 1432 |
Links to iHOP | 1432 |
Sequence Information | |
Nucleotide Sequence | >1432 : length: 4353 TTCTCTCACGAAGCCCCGCCCGCGGAGAGGTTCCATATTGGGTAAAATCTCGGCTCTCGG AGAGTCCCGGGAGCTGTTCTCGCGAGAGTACTGCGGGAGGCTCCCGTTTGCTGGCTCTTG GAACCGCGACCACTGGAGCCTTAGCGGGCGCAGCAGCTGGAACGGGAGTACTGCGACGCA GCCCGGAGTCGGCCTTGTAGGGGCGAAGGTGCAGGGAGATCGCGGCGGGCGCAGTCTTGA GCGCCGGAGCGCGTCCCTGCCCTTAGCGGGGCTTGCCCCAGTCGCAGGGGCACATCCAGC CGCTGCGGCTGACAGCAGCCGCGCGCGCGGGAGTCTGCGGGGTCGCGGCAGCCGCACCTG CGCGGGCGACCAGCGCAAGGTCCCCGCCCGGCTGGGCGGGCAGCAAGGGCCGGGGAGAGG GTGCGGGTGCAGGCGGGGGCCCCACAGGGCCACCTTCTTGCCCGGCGGCTGCCGCTGGAA AATGTCTCAGGAGAGGCCCACGTTCTACCGGCAGGAGCTGAACAAGACAATCTGGGAGGT GCCCGAGCGTTACCAGAACCTGTCTCCAGTGGGCTCTGGCGCCTATGGCTCTGTGTGTGC TGCTTTTGACACAAAAACGGGGTTACGTGTGGCAGTGAAGAAGCTCTCCAGACCATTTCA GTCCATCATTCATGCGAAAAGAACCTACAGAGAACTGCGGTTACTTAAACATATGAAACA TGAAAATGTGATTGGTCTGTTGGACGTTTTTACACCTGCAAGGTCTCTGGAGGAATTCAA TGATGTGTATCTGGTGACCCATCTCATGGGGGCAGATCTGAACAACATTGTGAAATGTCA GAAGCTTACAGATGACCATGTTCAGTTCCTTATCTACCAAATTCTCCGAGGTCTAAAGTA TATACATTCAGCTGACATAATTCACAGGGACCTAAAACCTAGTAATCTAGCTGTGAATGA AGACTGTGAGCTGAAGATTCTGGATTTTGGACTGGCTCGGCACACAGATGATGAAATGAC AGGCTACGTGGCCACTAGGTGGTACAGGGCTCCTGAGATCATGCTGAACTGGATGCATTA CAACCAGACAGTTGATATTTGGTCAGTGGGATGCATAATGGCCGAGCTGTTGACTGGAAG AACATTGTTTCCTGGTACAGACCATATTAACCAGCTTCAGCAGATTATGCGTCTGACAGG AACACCCCCCGCTTATCTCATTAACAGGATGCCAAGCCATGAGGCAAGAAACTATATTCA GTCTTTGACTCAGATGCCGAAGATGAACTTTGCGAATGTATTTATTGGTGCCAATCCCCT GGCTGTCGACTTGCTGGAGAAGATGCTTGTATTGGACTCAGATAAGAGAATTACAGCGGC CCAAGCCCTTGCACATGCCTACTTTGCTCAGTACCACGATCCTGATGATGAACCAGTGGC CGATCCTTATGATCAGTCCTTTGAAAGCAGGGACCTCCTTATAGATGAGTGGAAAAGCCT GACCTATGATGAAGTCATCAGCTTTGTGCCACCACCCCTTGACCAAGAAGAGATGGAGTC CTGAGCACCTGGTTTCTGTTCTGTTGATCCCACTTCACTGTGAGGGGAAGGCCTTTTCAC GGGAACTCTCCAAATATTATTCAAGTGCCTCTTGTTGCAGAGATTTCCTCCATGGTGGAA GGGGGTGTGCGTGCGTGTGCGTGCGTGTTAGTGTGTGTGCATGTGTGTGTCTGTCTTTGT GGGAGGGTAAGACAATATGAACAAACTATGATCACAGTGACTTTACAGGAGGTTGTGGAT GCTCCAGGGCAGCCTCCACCTTGCTCTTCTTTCTGAGAGTTGGCTCAGGCAGACAAGAGC TGCTGTCCTTTTAGGAATATGTTCAATGCAAAGTAAAAAAATATGAATTGTCCCCAATCC CGGTCATGCTTTTGCCACTTTGGCTTCTCCTGTGACCCCACCTTGACGGTGGGGCGTAGA CTTGACAACATCCCACAGTGGCACGGAGAGAAGGCCCATACCTTCTGGTTGCTTCAGACC TGACACCGTCCCTCAGTGATACGTACAGCCAAAAAGGACCAACTGGCTTCTGTGCACTAG CCTGTGATTAACTTGCTTAGTATGGTTCTCAGATCTTGACAGTATATTTGAAACTGTAAA TATGTTTGTGCCTTAAAAGGAGAGAAGAAAGTGTAGATAGTTAAAAGACTGCAGCTGCTG AAGTTCTGAGCCGGGCAAGTCGAGAGGGCTGTTGGACAGCTGCTTGTGGGCCCGGAGTAA TCAGGCAGCCTTCATAGGCGGTCATGTGTGCATGTGAGCACATGCGTATATGTGCGTCTC TCTTTCTCCCTCACCCCCAGGTGTTGCCATTTCTCTGCTTACCCTTCACCTTTGGTGCAG AGGTTTCTTGAATATCTGCCCCAGTAGTCAGAAGCAGGTTCTTGATGTCATGTACTTCCT GTGTACTCTTTATTTCTAGCAGAGTGAGGATGTGTTTTGCACGTCTTGCTATTTGAGCAT GCACAGCTGCTTGTCCTGCTCTCTTCAGGAGGCCCTGGTGTCAGGCAGGTTTGCCAGTGA AGACTTCTTGGGTAGTTTAGATCCCATGTCACCTCAGCTGATATTATGGCAAGTGATATC ACCTCTCTTCAGCCCCTAGTGCTATTCTGTGTTGAACACAATTGATACTTCAGGTGCTTT TGATGTGAAAATCATGAAAAGAGGAACAGGTGGATGTATAGCATTTTTATTCATGCCATC TGTTTTCAACCAACTATTTTTGAGGAATTATCATGGGAAAAGACCAGGGCTTTTCCCAGG AATATCCCAAACTTCGGAAACAAGTTATTCTCTTCACTCCCAATAACTAATGCTAAGAAA TGCTGAAAATCAAAGTAAAAAATTAAAGCCCATAAGGCCAGAAACTCCTTTTGCTGTCTT TCTCTAAATATGATTACTTTAAAATAAAAAAGTAACAAGGTGTCTTTTCCACTCCTATGG AAAAGGGTCTTCTTGGCAGCTTAACATTGACTTCTTGGTTTGGGGAGAAATAAATTTTGT TTCAGAATTTTGTATATTGTAGGAATCCTTTGAGAATGTGATTCCTTTTGATGGGGAGAA AGGGCAAATTATTTTAATATTTTGTATTTTCAACTTTATAAAGATAAAATATCCTCAGGG GTGGAGAAGTGTCGTTTTCATAACTTGCTGAATTTCAGGCATTTTGTTCTACATGAGGAC TCATATATTTAAGCCTTTTGTGTAATAAGAAAGTATAAAGTCACTTCCAGTGTTGGCTGT GTGACAGAATCTTGTATTTGGGCCAAGGTGTTTCCATTTCTCAATCAGTGCAGTGATACA TGTACTCCAGAGGGACAGGGTGGACCCCCTGAGTCAACTGGAGCAAGAAGGAAGGAGGCA GACTGATGGCGATTCCCTCTCACCCGGGACTCTCCCCCTTTCAAGGAAAGTGAACCTTTA AAGTAAAGGCCTCATCTCCTTTATTGCAGTTCAAATCCTCACCATCCACAGCAAGATGAA TTTTATCAGCCATGTTTGGTTGTAAATGCTCGTGTGATTTCCTACAGAAATACTGCTCTG AATATTTTGTAATAAAGGTCTTTGCACATGTGACCACATACGTGTTAGGAGGCTGCATGC TCTGGAAGCCTGGACTCTAAGCTGGAGCTCTTGGAAGAGCTCTTCGGTTTCTGAGCATAA TGCTCCCATCTCCTGATTTCTCTGAACAGAAAACAAAAGAGAGAATGAGGGAAATTGCTA TTTTATTTGTATTCATGAACTTGGCTGTAATCAGTTATGCCGTATAGGATGTCAGACAAT ACCACTGGTTAAAATAAAGCCTATTTTTCAAATTTAGTGAGTTTCTCAAGTTTATTATAT TTTTCTCTTGTTTTTATTTAATGCACAATATGGCATTATATCAATATCCTTTAAACTGTG ACCTGGCATACTTGTCTGACAGATCTTAATACTACTCCTAACATTTAGAAAATGTTGATA AAGCTTCTTAGTTGTACATTTTTTGGTGAAGAGTATCCAGGTCTTTGCTGTGGATGGGTA AAGCAAAGAGCAAATGAACGAAGTATTAAGCATTGGGGCCTGTCTTATCTACACTCGAGT GTAAGAGTGGCCGAAATGACAGGGCTCAGCAGACTGTGGCCTGAGGGCCAAATCTGGCCC ACCACCTGTTTGGTGTAGCCTGCTAAGAATGGCTTTTACATTTTTAAATGGTTGGGAAAG AAAAAAAAAGAAGTAGTAGATTTTGTAGCATGTGATGTAAGTAATGTAAAACTTAAATTC CAGTATCCATAAATAAAGTTTTATGAGAACAGA |
Protein Sequence | >1432 : length: 360 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA QALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES |